Detalhe da pesquisa
1.
Observational cohort study of long-term outcomes of liver transplantation in haemophilia.
Haemophilia
; 30(1): 87-97, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38111071
2.
Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial.
Lancet Haematol
; 10(8): e612-e623, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37385272
3.
Hormones and thrombosis: risk across the reproductive years and beyond.
Transl Res
; 225: 9-19, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32599096
4.
Recombinant vs plasma-derived von Willebrand factor to prevent postpartum hemorrhage in von Willebrand disease.
Blood Adv
; 4(14): 3234-3238, 2020 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32692849
5.
An investigational RNAi therapeutic targeting antithrombin for the treatment of hemophilia A and B.
J Blood Med
; 9: 135-140, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30174468
6.
Gene therapy in hemophilia A: a cost-effectiveness analysis.
Blood Adv
; 2(14): 1792-1798, 2018 07 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-30042145
7.
Prevalence and correlates of thrombosis in adults with immune thrombocytopenia: An NIS study.
Thromb Res
; 172: 80-85, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30384039
8.
Feasibility of the Von Willebrand disease PREVENT trial.
Thromb Res
; 156: 8-13, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28577390
9.
Evidence-Based Minireview: For overweight or obese persons with hemophilia A, should factor VIII dosing be based on ideal or actual body weight?
Hematology Am Soc Hematol Educ Program
; 2021(1): 215-218, 2021 12 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34889357
10.
Measuring success in hemophilia gene therapy using a factor level & outcomes yardstick.
Expert Rev Hematol
; 11(2): 83-86, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29300108